Jafron Biomedical Co Ltd (300529)
Shenzhen Stock Exchange · China · prices in CNY · close of 20 Oct 2026
Key indicators
| Last close | CNY 15.24 |
|---|---|
| 52-week range | 14.73 – 21.66 |
| Return, 1 month / 3 months | +1.8% / −10.7% |
| Return, 1 year / 3 years | −28.7% / −22.7% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 26.2% |
| Worst drawdown (1 year) | -31.2% |
| Average daily value traded | 109.19M CNY |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Jafron Biomedical Co Ltd (300529) trades on the Shenzhen Stock Exchange in China. It last closed at CNY 15.24 on 20 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 754 of 2,821 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 28.7% and over the last three months it fell 10.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shenzhen Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -12.9% | ||
| From 52-week high | -29.4% | ||
| Momentum | 38 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.7% | ||
| 6-month return | -10.1% | ||
| 12-month return, skipping the last month | -30.0% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.2% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 109.19M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | 77 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.4% |
|---|---|
| 1 month | +1.8% |
| 3 months | −10.7% |
| 6 months | −10.1% |
| 1 year | −28.7% |
| 3 years | −22.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 15.65 / 17.49 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jun 2026 | CNY 0.5200 |
| 26 May 2025 | CNY 0.8000 |
| 31 May 2024 | CNY 0.4000 |
| 31 May 2023 | CNY 0.6700 |
| 10 Jun 2022 | CNY 0.9000 |
| 12 May 2021 | CNY 0.6600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shenzhen Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.